.png)
ARCH Venture Partners invests in advanced technology startups and early-stage companies, spanning information technology, life sciences, and physical sciences.
ARCH Venture Partners is a leading venture capital firm specializing in the early-stage development of groundbreaking technologies and companies in the life sciences sector. Founded in 1986, ARCH has a strong track record of investing in disruptive innovations that have the potential to transform industries, particularly in biotechnology, pharmaceuticals, and medical devices. The firm is known for its hands-on approach, working closely with founders and scientists to bring pioneering research from the lab to the marketplace.
ARCH Venture Partners focuses on high-impact areas such as gene editing, immunotherapy, synthetic biology, and precision medicine. By partnering with world-class scientists and entrepreneurs, ARCH helps translate cutting-edge scientific discoveries into viable companies that address some of the most pressing health challenges. The firm’s strategy involves not only providing capital but also leveraging its extensive network of industry experts, advisors, and strategic partners to guide portfolio companies through the complexities of early-stage growth and commercialization.
One of the key strengths of ARCH Venture Partners is its ability to identify and support high-risk, high-reward opportunities. The firm has a deep understanding of the scientific and technological trends driving the life sciences sector, allowing it to invest in companies that are positioned to lead in their respective fields. ARCH’s portfolio includes a wide range of successful startups that have gone on to achieve significant breakthroughs and market success, solidifying its reputation as a leading investor in life sciences innovation.
Our pitch deck template will guide you through the requirements of an Accelerator-ready presentation.
Kickstart Ventures, Inc., based in Quezon City, Philippines, invests in early- to early-growth stage tech startups globally. With backing from Globe Telecom, Ayala Corporation, and Singtel, it manages diverse investments across Singapore, Indonesia, Malaysia, Canada, USA, and Israel, offering startups unparalleled support through market access and expertise.
SOSV is a global venture capital firm in NYC, Newark, and San Francisco, with $1.5B AUM, focusing on early-stage startups in deep tech, hard tech, and life sciences. They offer pre-seed/seed funding of $250K to $525K and boast a diverse portfolio of 1,000+ companies, supporting human and planetary health, with flagship programs like HAX and IndieBio providing extensive resources.
Bessemer Venture Partners (BVP) is a global venture capital firm with offices in Tel Aviv, Silicon Valley, San Francisco, New York, London, Hong Kong, Boston, and Bangalore, investing $20B in enterprise, consumer, healthcare, fintech, deep tech, and crypto sectors to empower early to mature stage entrepreneurs, boasting 145+ IPOs and over 300 portfolio companies, rooted in a century-old history of steel industry innovation.
Fusion Fund, based in Palo Alto, CA, invests in early-stage startups in healthcare, enterprise AI, and industrial tech, focusing on data or technical edge. With expertise in robotics, mobility, connectivity, AI, and digital health, it supports U.S. and Canadian startups from pre-seed to Series A stages, leveraging a strong CXO network for strategic guidance.
